Breast cancer is the most prevalent cancer among women and the leading cause of cancer-
related deaths in this population. Recent advances in Immunotherapy, or combined …

Breast cancer is the most common and biggest health threat for women. There is an urgent
need to develop novel breast cancer therapies to overcome the shortcomings of …

For women, breast cancer (BC) is the most prevalent and serious health risk. To address the
drawbacks of traditional surgery and chemotherapy, such as increased side effects, low drug …

Breast cancer poses a significant health risk and remains the most prevalent cancer among
women. The side effects associated with traditional chemotherapy, such as neurotoxicity …

Breast cancer is the most common malignancy among women and is the second leading
cause of cancer-related death for women. Depending on the tumor grade and stage, breast …

Aims: Breast cancer is the most common malignancy among women in both high-and low-
resource settings. Conventional breast cancer therapies were inefficient and had low patient …

Immunotherapy represents a revolutionary paradigm in cancer management, showcasing its
potential to impede tumor metastasis and recurrence. Nonetheless, challenges including …

Breast cancer was first noted by the ancient Egyptians more than 3500 years ago. In India,
the US, and China about 221757, 287750, and 429105 cases of breast cancer were …

Cancer immunotherapy has become the new paradigm of cancer treatment. The introduction
and discovery of various therapeutic agents have also accelerated the application of …

Immunotherapy plays an important role in cancer treatment by activating or suppressing the
immune system. However, there are still a series of challenges to overcome regarding the …